combine@alvar.ug

Identification of Host Proteins Predictive of Early Stage Mycobacterium tuberculosis Infection

Identification of Host Proteins Predictive of Early Stage Mycobacterium tuberculosis Infection

Show simple record

dc.contributor.author Bark, Charles M.
dc.contributor.author Manceur, Ameur M.
dc.contributor.author Malone, LaShaunda L.
dc.contributor.author Nsereko, Mary
dc.contributor.author Okware, Brenda
dc.contributor.author Mayanja, Harriet K.
dc.contributor.author Joloba, Moses L.
dc.contributor.author Rajotte, Isabelle
dc.contributor.author Mentinova, Marija
dc.contributor.author Kay, Phyla
dc.contributor.author Lo, Seydina
dc.contributor.author Tremblay, Patrick
dc.contributor.author Stein, Catherine M.
dc.contributor.author Boom, W. Henry
dc.contributor.author Paramithiotis, Eustache
dc.date.accessioned 2021-01-01T21:58:13Z
dc.date.available 2021-01-01T21:58:13Z
dc.date.issued 2017
dc.identifier.issn 2352-3964
dc.identifier.uri http://combine.alvar.ug/handle/1/48220
dc.description.abstract The objective of this study was to identify blood-based protein biomarkers of early stage Mycobacterium tuberculosis (Mtb) infection. We utilized plasma and serum specimens from TB patients and their contacts (age >= 12) enrolled in a household contact study in Uganda. In the discovery phase cross-sectional samples from 104 HIV-uninfected persons classified as either active TB, latent Mtb infection (LTBI), tuberculin skin test (TST) converters, or persistent TST-negative were analyzed. Two hundred eighty-nine statistically significant (false discovery rate corrected p < 0.05) differentially expressed proteins were identified across all comparisons. Proteins associated with cellular immunity and lipid metabolism were induced early after Mtb infection. One hundred and fifty-nine proteins were selected for a targeted mass spectrometry assay. A set of longitudinal samples from 52 TST-negative subjects who converted to TST-positive or remained TST-negative were analyzed, and multivariate logistic regression was used to identify unique protein panels able to predict TST conversion with cross-validated AUC > 0.85. Panel performance was confirmed with an independent validation set of longitudinal samples from 16 subjects. These candidate protein biomarkers may allow for the identification of recently Mtb infected individuals at highest risk for developing active TB and most likely to benefit from preventive therapy. (C) 2017 The Authors. Published by Elsevier B.V.
dc.description.sponsorship National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [HHSN272200800047C]
dc.description.sponsorship Tuberculosis Research Unit from the National Institutes of Health National Institute of Allergy and Infectious Diseases [N01-AI95383, HHSN266200700022C/N01-AI70022]
dc.description.sponsorship NIH/NCRR CTSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)NIH National Center for Research Resources (NCRR) [KL2TR000440]
dc.description.sponsorship NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000440, KL2TR000440, KL2TR000440, KL2TR000440, KL2TR000440] Funding Source: NIH RePORTER
dc.description.sponsorship NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [N01AI095383, N01AI095383, N01AI095383, N01AI095383, N01AI095383, N01AI095383] Funding Source: NIH RePORTER
dc.language English
dc.publisher ELSEVIER SCIENCE BV
dc.relation.ispartof Ebiomedicine
dc.subject Tuberculosis
dc.subject Proteomics
dc.subject Ltbi
dc.subject Converter
dc.title Identification of Host Proteins Predictive of Early Stage Mycobacterium tuberculosis Infection
dc.type Article
dc.identifier.isi 000409430700024
dc.identifier.doi 10.1016/j.ebiom.2017.06.019
dc.identifier.pmid 28655597
dc.publisher.city AMSTERDAM
dc.publisher.address PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
dc.identifier.volume 21
dc.identifier.spage 150
dc.identifier.epage 157
dc.subject.wc Medicine, General & Internal
dc.subject.wc Medicine, Research & Experimental
dc.subject.sc General & Internal Medicine
dc.subject.sc Research & Experimental Medicine
dc.description.oa DOAJ Gold
dc.description.oa Green Published
dc.description.pages 8
dc.subject.kwp Latent Tuberculosis
dc.subject.kwp Household Contact
dc.subject.kwp Individuals
dc.subject.kwp Metabolism
dc.subject.kwp Biomarkers
dc.subject.kwp Proteomics
dc.subject.kwp Kampala
dc.subject.kwp Uganda
dc.description.affiliation Case Western Reserve Univ, TB Res Unit, 10900 Euclid Ave, Cleveland, OH 44106 USA
dc.description.affiliation Caprion Biosci, 201 President Kennedy Ave, Montreal, PQ H2X 3Y7, Canada
dc.description.affiliation Uganda Case Western Reserve Univ Res Collaborat, Kampala, Uganda
dc.description.affiliation Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda
dc.description.affiliation Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda
dc.description.affiliation Metrohlth Med Ctr, Div Infect Dis, Cleveland, OH USA
dc.description.email cmb148@case.edu
dc.description.corr Bark, CM (corresponding author), Case Western Reserve Univ, TB Res Unit, 10900 Euclid Ave, Cleveland, OH 44106 USA.
dc.description.orcid Stein, Catherine/0000-0002-9763-5023
dc.description.orcid Mayanja-Kizza, Harriet/0000-0002-9297-6208


This record appears in the collections of the following institution(s)

Show simple record

Search Entire Database


Browse

My Account